Clinical trial · Interventional
The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)
The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers
NCT04604873CI-TRIAL-00095436completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main objective is to show the impact on the quality of life (QoL) for adults patients with advanced cancer managed in day hospital of integrated palliative care of cancer center (HDJ-SPI).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer, Advanced | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hospital day care follow-up | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- No hospital one day care
- description
- No hospital one day care
- type
- OTHER
- label
- Hospital one day care
- description
- Hospital one day care
- interventionNames
- Other: Hospital day care follow-up
Primary outcomes (1)
- measure
- Analyse impact of hospital day care in integrated palliative care department on quality of life of adult patients with advanced stage cancer
- timeFrame
- 12 months
- description
- Analyse impact of hospital day care in integrated palliative care department on quality of life of adult patients with advanced stage cancer Outcome shall be evaluated by assessing Survival without quality of life deterioration,measured by EORTC QLQ-C30 scale with monthly evaluation targeting three dimensions : global quality of life/ fatigue/ patient emotional state
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patient ≥ 18 years old with advanced solid tumor 2. Addressed for the first time to the palliative care team according to current criteria (medico-psycho-social symptoms, progressive risks) 3. With or without anti-cancer treatment 4. With estimated life expectancy of more than 2 months and less than 12 months 5. Able to communicate in French and answer questionnaires 6. Affiliated with a social security system 7. Having signed informed consent, co-signed by the partner if designated by the patient Exclusion Criteria: 1. Patient with primitive brain tumor or malignant hemopathy 2. Severe psychopathological disorders 3. Pregnant patient or childbearing potential without effective method of birth control 4. Unable to be followed at the cancer center until death 5. Patient deprived of liberty or under guardianship -
References
Publications (1)
- DERIVEDMarret L, Anota A, Waechter L, Laouisset C, Marchal T, Burnod A, Angellier E, Djoumakh OEK, Thebaut C, Bredart A, Dolbeault S, Mino JC, Bouleuc C. Palliative care in day-hospital for advanced cancer patients: a study protocol for a multicentre randomized controlled trial. BMC Palliat Care. 2021 Apr 17;20(1):61. doi: 10.1186/s12904-021-00754-x. PMID 33865379